November 5, 2019
Apella by Alexandria,
New York, NY 10016
The meeting place of peers and industry leaders in the NY/NJ biopharm community
This invitation-only, off-the-record forum brings together senior-level life sciences executives to network and share insights into the industry's challenges and opportunities.
2018 Event Highlights
NY/NY CEO provides networking chemistry at its finest. You can hear the deals being hatched. Join your senior level community in shaping the future of biotech.
Keynote with Alex Denner on Board Governance
Check out the keynote discussion on Board Governance which featured Alex Denner, Hedge Fund Operator and CIO of Sarissa Capital Management, arguably one of the biggest influencers in biopharma today.
War Stories with Jeremy Levin
Industry veteran, Jeremy Levin, CEO, Ovid Therapeutics, candidly shared his war stories on-site.
Capital Investment, Partnerships, Market Outlooks
Keep your finger on the pulse of what is happening nationally in capital investment, partnerships, market outlooks and the state of the industry, plus how that plays out at the local level.
New York Investment Opportunities & Funding Initiatives
Senior-level peers sat in on a VC panel to hear what makes New York a unique opportunity for investment and biotech building.
Get an update on how funding initiatives are overcoming the challenges in real estate and talent for biotech development in New York.
A Focus on Innovative LS Tech Companies
Experience a spotlight session on Innovative Tech Life Science companies and feed your visionary ideas.
Interested in sponsorship opportunities?
Sponsor an upcoming LeadingBiotech event to enhance your visibility and demonstrate your expertise to a highly qualified audience of c-level decision makers. All programs are custom-built to align with your unique objectives and may include speaking engagement, passes, branding, and more.
2018 Steering Committee
Meet the NY/NJ CEO Steering Committee, a distinguished group of industry thought leaders whose insights have helped shape our program into one that brings the most relevant players in the biopharma space to the table.